`Par v. Horizon, IPR 2018-01550
`Page 1 of 2
`
`
`
`Regards,
`David Silverstein
`Lead Counsel for Petitioner
`
`
`
`
`David H. Silverstein
`Partner
`
`
`
`
`
`Axinn, Veltrop & Harkrider LLP
`114 West 47th Street
`New York, New York 10036
`Office 212.261.5651
`Fax 212.728.2201
`dsilverstein@axinn.com
`Axinn.com
`
`
`Click here to send a secure file via ShareFile.
`
`
`**********************************************************************
`Notice: The information contained in this electronic mail and any attached documents from Axinn, Veltrop &
`Harkrider LLP is confidential. This email may be an attorney-client communication, and as such is privileged
`and confidential. If you are not the intended recipient, be aware that any disclosure, copying, distribution or use
`of the content of this information is prohibited. If you have received this electronic mail in error, please notify
`us immediately by telephone (212) 728-2200/(860) 275-8100 or by reply electronic mail to the sender. IRS
`Circular 230 disclosure: To ensure compliance with requirements imposed by the IRS, we inform you that any
`U.S. federal tax advice contained in this communication (including any attachments) is not intended or written
`to be used, and cannot be used, for the purpose of (i) avoiding penalties under the Internal Revenue Code or (ii)
`promoting, marketing or recommending to another party any transaction or matter addressed herein.
`**********************************************************************
`
`2
`
`Par Pharmaceutical, Inc. Ex. 1037
`Par v. Horizon, IPR 2018-01550
`Page 2 of 2
`
`